sorafenib has been researched along with acitretin in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (acitretin) | Trials (acitretin) | Recent Studies (post-2010) (acitretin) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 1,328 | 95 | 548 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Iannattone, L; LeBoeuf, NR; Said, JT; Sauder, M; Singer, S | 1 |
1 review(s) available for sorafenib and acitretin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for sorafenib and acitretin
| Article | Year |
|---|---|
Outcomes of Acitretin Treatment for Refractory Multikinase Inhibitor-Induced Hand-Foot Skin Reaction.
Topics: Acitretin; Hand-Foot Syndrome; Humans; Skin; Sorafenib | 2022 |